1
Nov
2022

August Bioservices

Exhibitor at CPHI Frankfurt 2022 stand 90D91, ICSE
About Us

August Bioservices is a US-based, quality-driven CDMO that offers end-to-end drug research and development, cGMP laboratory services, and sterile fill/finish cGMP manufacturing to clients of all sizes and stages, from pre-clinical to commercial, all under one roof.
Focus Areas: sterile injectables, topicals, high-complexity formulations, poorly soluble & highly viscous compounds, uncommon container sizes & fill volumes


Expanded capacity with multiple new fill/finish lines is coming online in 2022.


Tech transfer can begin immediately with fill/finish manufacturing slots available starting in Q4 2022.

Clients of all sizes choose August Bio because we’re a unique hybrid – offering the deep expertise, state-of-the-art instrumentation and comprehensive capabilities of a large CDMO, supported by a high-touch, highly collaborative and responsive customer service team.

  • US
  • 2021
    On CPHI since
  • 2
    Certificates
  • 50 - 99
    Employees
Company types
CMO/CDMO
Primary activities
Analytical Services
Contract Manufacturer
Laboratory Services
Contact info
Event information
CPHI Frankfurt 2022
  • 1-3 November 2022
  • Messe Frankfurt, Germany
  • Visit us at stand 90D91, ICSE

Products Featured at CPHI Frankfurt 2022